Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Magnetic Resonance Imaging Systems market in this environment.
In terms of revenue, this research report indicated that the global Magnetic Resonance Imaging Systems market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Magnetic Resonance Imaging Systems industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Aurora Imaging Technology aims at producing XX K Units Magnetic Resonance Imaging Systems in 2020, with XX % production to take place in global market, Esaote accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Magnetic Resonance Imaging Systems Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Magnetic Resonance Imaging Systems Market
Aurora Imaging Technology
Esaote
Fonar Corporation
GE Healthcare
Hitachi Medical Corporation
IMRIS
Neusoft Medical Systems
Philips Healthcare
Siemens Healthcare
Toshiba Medical Systems Corporation
...
Major Type of Magnetic Resonance Imaging Systems Covered in Prudent Markets report:
Closed MRI Systems
Open MRI Systems
Application Segments Covered in Prudent Markets Market
Brain and Neurological MRI
Spine and Musculoskeletal MRI
Cardiac MRI
Pelvic and Abdominal MRI
Breast MRI
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Magnetic Resonance Imaging Systems Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Closed MRI Systems -Product Introduction and Major Manufacturers
1.1.2 Open MRI Systems -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Magnetic Resonance Imaging Systems Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Magnetic Resonance Imaging Systems Market
3.1.1 Top Companies leading Magnetic Resonance Imaging Systems Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Magnetic Resonance Imaging Systems Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Magnetic Resonance Imaging Systems Market
3.2.1 Top Companies leading Magnetic Resonance Imaging Systems Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Magnetic Resonance Imaging Systems Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Magnetic Resonance Imaging Systems Market
3.3.1 Top Companies leading Magnetic Resonance Imaging Systems Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Magnetic Resonance Imaging Systems Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Magnetic Resonance Imaging Systems Market
3.4.1 Top Companies leading Magnetic Resonance Imaging Systems Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Magnetic Resonance Imaging Systems Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Magnetic Resonance Imaging Systems Market
3.5.1 Top Companies leading Magnetic Resonance Imaging Systems Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Magnetic Resonance Imaging Systems Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Magnetic Resonance Imaging Systems Market
3.6.1 Top Companies leading Magnetic Resonance Imaging Systems Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Magnetic Resonance Imaging Systems Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Magnetic Resonance Imaging Systems Market
3.7.1 Top Companies leading Magnetic Resonance Imaging Systems Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Magnetic Resonance Imaging Systems Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Magnetic Resonance Imaging Systems Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Magnetic Resonance Imaging Systems Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Magnetic Resonance Imaging Systems Sales and Growth Rate (2021-2027)
5.2 Global Magnetic Resonance Imaging Systems Sales Value and Growth Rate (2021-2027)
6 Magnetic Resonance Imaging Systems Competitive Analysis
6.1 Aurora Imaging Technology
6.1.1 Aurora Imaging Technology Company Profiles
6.1.2 Aurora Imaging Technology Product Introduction
6.1.3 Aurora Imaging Technology Magnetic Resonance Imaging Systems Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Esaote
6.2.1 Esaote Company Profiles
6.2.2 Esaote Product Introduction
6.2.3 Esaote Magnetic Resonance Imaging Systems Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Fonar Corporation
6.3.1 Fonar Corporation Company Profiles
6.3.2 Fonar Corporation Product Introduction
6.3.3 Fonar Corporation Magnetic Resonance Imaging Systems Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 GE Healthcare
6.4.1 GE Healthcare Company Profiles
6.4.2 GE Healthcare Product Introduction
6.4.3 GE Healthcare Magnetic Resonance Imaging Systems Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Hitachi Medical Corporation
6.5.1 Hitachi Medical Corporation Company Profiles
6.5.2 Hitachi Medical Corporation Product Introduction
6.5.3 Hitachi Medical Corporation Magnetic Resonance Imaging Systems Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 IMRIS
6.6.1 IMRIS Company Profiles
6.6.2 IMRIS Product Introduction
6.6.3 IMRIS Magnetic Resonance Imaging Systems Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Neusoft Medical Systems
6.7.1 Neusoft Medical Systems Company Profiles
6.7.2 Neusoft Medical Systems Product Introduction
6.7.3 Neusoft Medical Systems Magnetic Resonance Imaging Systems Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Philips Healthcare
6.8.1 Philips Healthcare Company Profiles
6.8.2 Philips Healthcare Product Introduction
6.8.3 Philips Healthcare Magnetic Resonance Imaging Systems Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Siemens Healthcare
6.9.1 Siemens Healthcare Company Profiles
6.9.2 Siemens Healthcare Product Introduction
6.9.3 Siemens Healthcare Magnetic Resonance Imaging Systems Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Toshiba Medical Systems Corporation
6.10.1 Toshiba Medical Systems Corporation Company Profiles
6.10.2 Toshiba Medical Systems Corporation Product Introduction
6.10.3 Toshiba Medical Systems Corporation Magnetic Resonance Imaging Systems Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
7 Conclusion